These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 10342583

  • 1. Possible role of granulocyte colony-stimulating factor in increased serum soluble interleukin-2 receptor-alpha levels after allogeneic bone marrow transplantation.
    Kobayashi S, Imamura M, Hashino S, Noto S, Mori A, Tanaka J, Naohara T, Kasai M, Asaka M.
    Leuk Lymphoma; 1999 May; 33(5-6):559-66. PubMed ID: 10342583
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.
    Kobayashi S, Imamura M, Hashino S, Tanaka J, Asaka M.
    Leuk Lymphoma; 1997 Dec; 28(1-2):159-69. PubMed ID: 9498715
    [Abstract] [Full Text] [Related]

  • 3. Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
    Dreger P, Grelle K, Eckstein V, Suttorp M, Müller-Ruchholtz W, Löffler H, Schmitz N.
    Br J Haematol; 1993 Jan; 83(1):7-13. PubMed ID: 7679589
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease.
    Kami M, Matsumura T, Tanaka Y, Mikami Y, Miyakoshi S, Ueyama J, Morinaga S, Mori S, Machida U, Kanda Y, Chiba S, Sakamaki H, Hirai H, Muto Y.
    Leuk Lymphoma; 2000 Aug; 38(5-6):533-40. PubMed ID: 10953974
    [Abstract] [Full Text] [Related]

  • 9. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J, Zhao XY, Huang XJ.
    Zhonghua Yi Xue Za Zhi; 2005 Sep 14; 85(35):2497-502. PubMed ID: 16321278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR, Ji SQ, Wang HX, Yan HM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug 14; 10(4):340-6. PubMed ID: 12513770
    [Abstract] [Full Text] [Related]

  • 13. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N, Chamakhi I, Perreault C, Roy DC, Sauvageau G, Ducruet T, Busque L, Fish D, Bélanger R, Roy J.
    Exp Hematol; 2006 Jan 14; 34(1):107-14. PubMed ID: 16413397
    [Abstract] [Full Text] [Related]

  • 14. Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.
    Nakamura Y, Tanaka Y, Tanaka M, Sugiyama A, Yamamoto K, Tokunaga Y, Yujiri T, Tanizawa Y.
    Int J Hematol; 2016 Apr 14; 103(4):436-43. PubMed ID: 26791380
    [Abstract] [Full Text] [Related]

  • 15. Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias.
    Engelhard D, Nagler A, Singer R, Barak V.
    Leuk Lymphoma; 1994 Jan 14; 12(3-4):273-80. PubMed ID: 8167558
    [Abstract] [Full Text] [Related]

  • 16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan 14; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan 14; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow.
    Busch FW, Pilgrim TB, Krämer A, Ehninger G.
    Bone Marrow Transplant; 1997 Apr 14; 19(7):653-9. PubMed ID: 9156241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.